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General methods
Optical rotations were measured with a Perkin Elmer 341 polarimeter, using a sodium lamp ( = 589 nm) at 25 ºC in 1 dm tubes. NMR experiments were performed using Bruker Avance III-400 and DRX-500 spectrometers. 2-D COSY and HSQC experiments were carried out to assist in signal assignment. Unit A refers to the reducing end monosaccharide in the NMR data. For electrospray mass spectra (ESIMS), we employed a Bruker Esquire 6000 equipment.
High-resolution mass spectra (HRMS) were performed at Centro de Investigación, Tecnología e Innovación, University of Seville (CITIUS). Thin-layer chromatography (TLC) analyses were performed on silica gel 60F-254 precoated plates from Merck. The compounds were detected by UV visualization ( = 254 nm) and by staining with 5% v/v anisaldehyde/5% v/v H 2 SO 4 /0.2% v/v AcOH in EtOH or 0.2% w/v cerium (IV) sufate/5% w/v ammonium molybdate tetrahydrate in 1 M H 2 SO 4 followed by heating at over 200 ºC. Column chromatography was performed on silica gel 60 from Merck (15-40 µm or 63-200 µm). For F-SPE purification, we followed our previously reported experimental procedure [1, 2] . Briefly, FluoroFlash silica gel (5 g., from
Sigma-Aldrich) was introduced in a glass chromatography column (1.7 cm diameter). The F-SPE column was washed with DMF (2 mL) and then preconditioned with MeOH/H 2 O 4:1 (15 mL). Next, the crude sample (100-300 mg) was dissolved in DMF/H 2 O 9:1 (0.8 mL) and loaded on the column. The fluorophobic elution was carried out with 15 mL of MeOH/H 2 O 4:1. The fluorous compounds were then eluted using 100% acetone (20 mL).
4-Methoxyphenyl 3-O-(methyl 4-O-levulinyl-2,3-di-O-pivaloyl-β-Dglucopyranosyluronate)-4,6-O-di-tert-butylsilylene-2-deoxy-2-trifluoroacetamido-β-Dgalactopyranoside (5).
In a manner similar to a procedure from [3] , glycosyl acceptor 4 (162 mg, 0.311 mmol) and D-glucuronic acid trichloroacetimidate 3 (270 mg, 0.436 mmol) were combined in a flask, coevaporated with toluene and dried under vacuum. The starting materials were dissolved in dry CH 2 Cl 2 (4 mL) and further dried by stirring over freshly activated 4 Å molecular sieves for 15 min. TMSOTf (158 µL of a 0.28 M solution in CH 2 Cl 2 ; 0.044 mmol) was added at 0 ºC. After 30 min at 0 ºC, the reaction was quenched with Et 3 N (2 mL) and filtered, and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography using 1:1 EtOAc-petroleum ether as eluent to give compound 5 as a colourless oil (294 mg, 97%). R f 0.30 (1:1 EtOAc/petroleum ether). [α] 
3-O-(Methyl 4-O-levulinyl-2,3-di-O-pivaloyl-β-D-glucopyranosyluronate)-4,6-di-Oacetyl-2-deoxy-2-trifluoroacetamido-α-D-galactopyranose (8)
. CAN (260 mg, 0.476 mmol) was added to a solution of 7 (110 mg, 0.119 mmol) in CH 3 CN/CH 2 Cl 2 /water (6:3:1, 6.7 mL) and the mixture was stirred for 1 h at 0 ºC. Then, the mixture was diluted with EtOAc, washed with water and saturated aqueous NaHCO 3 solution, dried (MgSO 4 ), filtered and concentrated in vacuo. The resulting residue was purified by column chromatography using 3:1 EtOAcpetroleum ether as eluent to give compound 8 as a pale yellow amorphous solid (96 mg, 99%). 
O-[3-O-(Methyl 4-O-levulinyl-2,3-di-O-pivaloyl-β-D-glucopyranosyluronate)-4,6-di-
O-acetyl-2-deoxy-2-trifluoroacetamido-α,β-D-galactopyranosyl] trichloroacetimidate (1).
In a manner similar to a procedure from [3] , trichloroacetonitrile (147 µL, 1.47 mmol) and catalitic DBU (60 µL of a 0.084 M solution in dry CH 2 Cl 2 ) were added to a solution of 8 (80 mg, 0.098 mmol) in dry CH 2 Cl 2 (3 mL). After stirring for 9 h at room temperature, the reaction mixture was concentrated to dryness. The residue was purified by column chromatography 4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoyl 
4-Methoxyphenyl
98.3 (C-1B), 91.4 (C-1A), 72.3 (C-5B), 71.3 (C-3B), 69.7 (C-3A or C-5A), 69.4, 69.3 (C-2B, C- 4B), 68.5 (C-4A), 67.3 (C-3A or C-5A), 62.4 (C-6A),
O-[3-O-(Methyl 4-O-levulinyl-2,3-di-O-pivaloyl-β-D-glucopyranosyluronate)-4-O-
acetyl-2-deoxy-6-O-4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoyl-2-
trifluoroacetamido-α,β-D-galactopyranosyl] trichloroacetimidate (12).
In a manner similar to a procedure from [3] , trichloroacetonitrile (100 µL, 0. 1, 176.5, 170.6, 170.0, 168.9 (CO, Piv, COOMe, Ac, COCH 2 CH 2 C 8 F 17 ), 157.7 (q, COCF 3 ), 115.4 (q, COCF 3 ), 100.0 (C-1B), 
2-Propyl 3-O-(methyl 4-O-levulinyl
2-Propyl 3-O-(methyl 2,3-di-O-pivaloyl-β-D-glucopyranosyluronate)-4-O-acetyl-2-
97.4 (C-1A), 74.1 (C-4B, C-5A, C-5B or CH isopropyl), 73.5 (C-3B), 72.9 (C-4B, C-5A, C-5B or CH isopropyl), 71.8 (C-3A), 71.1 (C-4B, C-5A, C-5B or CH isopropyl), 70.6 (C-2B), 70.2 (C-4B, C-5A, C-5B or CH isopropyl), 69.1 (C-4A), 62.8 (C-6A), 55.7 (C-2A),
2-Propyl O-(methyl 4-O-levulinyl-2,3-di-O-pivaloyl-β-D-glucopyranosyluronate)-(1→3)-O-(4,6-di-O-acetyl-2-deoxy-2-trifluoroacetamido-α,β-D-galactopyranosyl)-(1→4)
-
4-Methoxyphenyl 3-O-(sodium β-D-glucopyranosyluronate)-2-acetamido-2-deoxy-β-D-galactopyranoside (15). In a manner similar to a procedure from [4], H 2 O 2 (30%, 1.2 mL)
and an aqueous solution of LiOH (0.7 M, 0.72 mL) were added at −5 ºC to a solution of 6 (25 mg, 0.030 mmol) in THF (1 mL). After stirring for 24 h at room temperature, MeOH (2 mL) and an aqueous solution of NaOH (4 M, 0.76 mL) were added. After 72 h at room temperature, the mixture was neutralized with Amberlite IR-120 (H + ) resin and then, a drop of Et 3 N was added. The mixture was filtered, concentrated and coevaporated several times with MeOH. Et 3 N (55 µL) and Ac 2 O (60 µL) were added at 0 ºC to a solution of the reaction crude in MeOH (3 mL). After stirring for 2 h at room temperature, Et 3 N (1 mL) was added and the mixture was concentrated to dryness. The residue was purified by Sephadex G-10 
2-Propyl O-(sodium β-D-glucopyranosyluronate)-(1→3)-O-(2-acetamido-2-deoxy-α-D-galactopyranosyl)-(1→4)-O-(sodium β-D-glucopyranosyluronate)-(1→3)-2-acetamido-
2-deoxy-β-D-galactopyranoside (16α
2-Propyl O-(sodium β-D-glucopyranosyluronate)-(1→3)-O-(2-acetamido-2-deoxy-β-D-galactopyranosyl)-(1→4)-O-(sodium β-D-glucopyranosyluronate)-(1→3)-2-acetamido-
2-deoxy-β-D-galactopyranoside (16β)
. H 2 O 2 (30%, 1.2 mL) and an aqueous solution of LiOH (0.7 M, 0.7 mL) were added at −5 ºC to a solution of 14β (22 mg, 0.011 mmol) in THF (1 mL).
After stirring for 24 h at room temperature, MeOH (2 mL) and an aqueous solution of NaOH (4 M, 0.76 mL) were added. After 72 h at room temperature, the mixture was neutralized with Hz, CH 3 (isopropyl)). 13 H, CH 3 (Ac)), 1.23 (d, 3 H, 3 J H,H = 6.2 Hz, CH 3 (isopropyl)), 1.12, 1.11 (s, 18 H, CH 3 (Piv)), 1.11 (m, 3 H, CH 3 (isopropyl) ). 13 2, 21.7 (CH 3 , isopropyl), 20.7, 20.6 (CH 3 , Ac (Piv)), 1.13 (m, 3 H, CH 3 (isopropyl) ). was added at 0 ºC. After 30 min at 0 ºC, the reaction was quenched with Et 3 N (1 mL) and filtered, and the solvent was removed under reduced pressure. The residue was purified by column chromatography using 100:1→80:1→60:1 CH 2 Cl 2 /MeOH as eluent to give compounds 21α (10 mg, 18%) and 21β (11 mg, 20%) as colourless oils and unreacted 20 (11 mg, 31%). 
2-Propyl 3-O-(methyl 4-O-levulinyl-2,3-di-O-pivaloyl-β-D-glucopyranosyluronate)-
4,6-di-O-acetyl-2-deoxy-2-trifluoroacetamido-β-D-galactopyranoside (17
2-Propyl
